Unipharma Co (ROCO:6621) EPS (Basic) : NT$-0.70 (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Unipharma Co EPS (Basic)?

Unipharma Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$-0.42. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-0.70.

Unipharma Co's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-0.42. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-0.70.

Unipharma Co's EPS without NRI for the six months ended in Dec. 2024 was NT$-0.42. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -0.70.

During the past 3 years, the average EPS without NRI Growth Rate was 30.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Unipharma Co's highest 3-Year average EPS without NRI Growth Rate was 36.70% per year. The lowest was -15.80% per year. And the median was 28.90% per year.

Unipharma Co EPS (Basic) Historical Data

The historical data trend for Unipharma Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unipharma Co EPS (Basic) Chart

Unipharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-1.57

-2.11

-0.18

-0.61

-0.70

Unipharma Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-0.25	-0.15	-0.46	-0.28	-0.42

Unipharma Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Unipharma Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-24.819	-	0)	/	35.501
	=	-0.70

Unipharma Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-15.025	-	0)	/	35.501
	=	-0.42

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.70

Unipharma Co (ROCO:6621) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Unipharma Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Unipharma Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Unipharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unipharma Co Ltd (ROCO:6621) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiu Zong Road, 3rd Floor, No. 17, Lane 171, Section 2, NeiHu District, Taipei, TWN, 11494

Website

http://www.uni-pharma.com

Unipharma Co Ltd is a medical diagnostic, pharmaceutical and medical device company. It is engaged in developing drug products and medical equipment. The company's products offerings include Baxter, Tambocor tablets, Bain Injection, Esmolol HCL Injection, Naloxone Injection, and SAM Pelvic Sling medical device. Its customers are major medical centers, regional hospitals, regional hospitals, and clinics.

Unipharma Co Headlines

No Headlines